Cargando…
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro
Pandemic spread of emerging human pathogenic viruses, such as the current SARS-CoV-2, poses both an immediate and future challenge to human health and society. Currently, effective treatment of infection with SARS-CoV-2 is limited and broad spectrum antiviral therapies to meet other emerging pandemi...
Autores principales: | Svenningsen, Esben B., Thyrsted, Jacob, Blay-Cadanet, Julia, Liu, Han, Lin, Shaoquan, Moyano-Villameriel, Jaime, Olagnier, David, Idorn, Manja, Paludan, Søren R., Holm, Christian K., Poulsen, Thomas B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687369/ https://www.ncbi.nlm.nih.gov/pubmed/33248195 http://dx.doi.org/10.1016/j.antiviral.2020.104988 |
Ejemplares similares
-
Expanding the antibacterial selectivity of polyether ionophore antibiotics through diversity focused semi-synthesis
por: Lin, Shaoquan, et al.
Publicado: (2021) -
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate
por: Olagnier, David, et al.
Publicado: (2020) -
Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate
por: Olagnier, David, et al.
Publicado: (2020) -
SARS‐CoV‐2 evades immune detection in alveolar macrophages
por: Dalskov, Louise, et al.
Publicado: (2020) -
Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium
por: Thyrsted, Jacob, et al.
Publicado: (2021)